The impact of continuous renal replacement therapy for metabolic disorders in infants

Fatih Aygun1, Deniz Aygun2, Firuze Erbek Alp3

  • 1Istanbul University, Cerrahpasa Medical Faculty, Department of Pediatric Intensive Care Unit, Istanbul, Turkey.

Insights

Continuous Renal Replacement Therapy (CRRT) effectively manages metabolic emergencies like hyperammonemia and high leucine levels in pediatric patients. This study highlights CRRT

Area of Science:

  • Pediatric Critical Care Medicine
  • Nephrology
  • Metabolic Disorders

Background:

  • Continuous Renal Replacement Therapy (CRRT) is established for acute kidney insufficiency (AKI).
  • Emerging use of CRRT in managing acute metabolic disorders, including hyperammonemia and elevated leucine levels.
  • Study focuses on CRRT application in a pediatric intensive care unit (PICU) setting.

Purpose of the Study:

  • To describe the experience with CRRT in treating acute decompensation of pediatric patients with metabolic disorders.
  • To evaluate the efficacy of CRRT in managing hyperammonemia and elevated leucine levels.
  • To report on the application of CRRT in a PICU over a one-year period.

Main Methods:

  • Retrospective evaluation of pediatric patients treated with CRRT for acute metabolic crisis.
  • Analysis of 14 patients admitted to the PICU between November 2014 and December 2015.
  • Inclusion of patients with hyperammonemia and elevated leucine levels due to various metabolic disorders.

Main Results:

  • 14 pediatric patients received CRRT for metabolic disorders.
  • 10 patients had hyperammonemia, and 4 had elevated leucine levels.
  • CRRT modalities included continuous veno-venous hemodiafiltration (CVVHDF) and continuous veno-venous hemodialysis (CVVHD) with high throughput settings.

Conclusions:

  • CRRT is an efficient treatment for metabolic emergencies such as hyperammonemia and elevated leucine levels.
  • The study supports the use of CRRT in managing severe metabolic decompensation in pediatric patients.
  • CRRT demonstrates effectiveness in addressing life-threatening metabolic crises.
Abstract

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.3K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
281
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
380
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
329
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
286
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
503